Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Drug Distribution: Tissue Binding

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Osteoporosis complicating some inborn or acquired diseases.

Physiological research·2018

Same author

Involvement of bone in systemic endocrine regulation.

Physiological research·2018

Same author

New molecules modulating bone metabolism - new perspectives in the treatment of osteoporosis.

Physiological research·2017

Same author

Hormonal and bone parameters in pubertal girls.

Physiological research·2017

Same author

Trace elements have beneficial, as well as detrimental effects on bone homeostasis.

Physiological research·2017

Same author

Hypercalcemia. Pathophysiological aspects.

Physiological research·2015

Search research articles

Related Experiment Video

Updated: May 12, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

[Drug induced osteoporosis].

¹Endokrinologický Úistav Praha, Feditelka doc. RNDr. Bela Bendlovd, CSc. izofkova@endo.cz

Vnitrni Lekarstvi

|April 9, 2013

Summary

Many common medications can cause bone loss and increase fracture risk. Early calcium and vitamin D supplementation can help reverse some skeletal damage, but awareness of drug-induced osteoporosis is crucial.

Area of Science:

Endocrinology
Pharmacology
Bone Biology

Context:

Bone loss is a common complication in patients undergoing treatment for chronic diseases.
Osteoporosis is often diagnosed late, typically after a fracture occurs.
Glucocorticoids, commonly used in internal medicine, significantly impact bone health.

Purpose:

To review the mechanisms by which various pharmaceuticals induce bone damage and increase fracture risk.
To highlight the early onset of bone loss associated with glucocorticoid therapy.
To discuss the role of hormonal imbalances and other drug classes in skeletal deterioration.

Summary:

Glucocorticoids impair osteoblast function, enhance osteoclast activity via RANKL, and reduce intestinal calcium absorption, leading to hypocalcemia and accelerated bone resorption.

More Related Videos

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 12, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Published on: September 27, 2024

Long-term thyroid hormone therapy and medications inducing hypoestrinism (e.g., aromatase inhibitors) or affecting bone cell differentiation (e.g., thiazolidinediones) also contribute to bone loss.

Other drug classes implicated include selective serotonin reuptake inhibitors, anti-epileptics, diuretics, anticoagulants, and proton pump inhibitors, all contributing to increased fracture risk.

Impact:

Early identification of patients at risk for drug-induced bone loss is critical for timely intervention.
Supplementation with vitamin D and calcium can mitigate some of the skeletal damage, particularly when initiated early.
Understanding these mechanisms can inform clinical practice and potentially lead to the development of bone-protective strategies during long-term pharmacotherapy.